Metraipolis › archive › dc_a3cb58828e3a

Monoclonal Gammopathy Prevalence in Newly Diagnosed Prostate Cancer Patients: A Correlative Perspective Observational Study — Europe PMC PMID:41374992

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41374992
DOI
10.3390/cancers17233790
License (as archived)
solo-consultazione
Archived
2026-11-08T05:27:46.920Z
SHA-256 of the archived text
da1d4f67a475221e483b9e52e5828b14c2e6f82c3a64d650966576b8c1f05c9e
Stable URL of this page
https://metraipolis.com/documento/dc_a3cb58828e3a

How to cite

Monoclonal Gammopathy Prevalence in Newly Diagnosed Prostate Cancer Patients: A Correlative Perspective Observational Study — Europe PMC PMID:41374992 — Europe PMC (en), https://europepmc.org/article/MED/41374992 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3cb58828e3a (Metraipolis archive dc_a3cb58828e3a, sha256 da1d4f67a475221e483b9e52e5828b14c2e6f82c3a64d650966576b8c1f05c9e)
BibTeX
@misc{dca3cb58828e3a,
  title = {Monoclonal Gammopathy Prevalence in Newly Diagnosed Prostate Cancer Patients: A Correlative Perspective Observational Study — Europe PMC PMID:41374992},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41374992},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3cb58828e3a; sha256 da1d4f67a475221e483b9e52e5828b14c2e6f82c3a64d650966576b8c1f05c9e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41374992. Agents can read the archived copy with the MCP tool read_document.